Navigation Links
HOPA Introduces Scope Of Hematology/Oncology Pharmacy Practice
Date:10/22/2013

CHICAGO, Oct. 22, 2013 /PRNewswire-USNewswire/ -- As oncology treatments become more personalized and complex, the role of the hematology/oncology pharmacist has expanded and become more comprehensive.  Recognizing that there is a significant disconnect in how hematology/oncology pharmacists are perceived by the public and, even other healthcare providers, and the crucial contributions they make to the cancer care team, the Hematology/Oncology Pharmacist Association (HOPA) developed a comprehensive document detailing their important role. "As an organization, we are excited to announce the release of this Scope of Hematology/Oncology Pharmacy Practice document. In addition to emphasizing and clarifying the role of hematology/oncology pharmacists, it can be used as a tool to educate health care leaders, the public, and policy makers on the impact these specially trained pharmacists can have in the care of cancer patients," says Niesha Griffith RPh MS FASHP, HOPA president.  

The Scope of Hematology/Oncology Pharmacy Practice is the first document to clearly define the knowledge, skills and functions of the hematology/oncology pharmacist, primarily related to direct patient care, and to promote a better understanding of this ever-growing profession. As a specialty area within pharmacy practice, the oncology pharmacist plays a vital role in treatment selection, management, research, education and even performance improvement.

Because oncology medications are often extremely toxic, require complicated preparation and administration, and are frequently expensive, having a specially trained hematology/oncology pharmacist as a member of the patient care team ensures an enhanced level of care. "Oncology pharmacists are able to improve medication safety, provide supportive care and support in making treatment decisions and ultimately impact a patient's quality of life. We hope that publishing this scope document will foster a more unified approach to data-driven, evidence-based support for the inclusion of oncology pharmacists into all cancer care settings," states Dr. Laura Michaud PharmD BCOP, co-editor. 

The Scope of Hematology Oncology Pharmacy Practice was developed to demonstrate that hematology/oncology pharmacists facilitate and improve patient care through evidence-based treatment selection, medication monitoring and modification, and symptom management.  Hematology/oncology pharmacists are also on the front lines addressing insurance coverage issues, providing patient education and advocating for improved cancer care in the health policy arena.  "Oncology pharmacists are involved in these aspects with individual patients, but are also involved in developing policies and guidelines that can improve patient safety as it relates to medications and their use in a variety of different health care settings. If more pharmacists were involved in these processes, patient care may be improved further," says immediate past president of HOPA and co-editor, Lisa Holle PharmD BCOP. 

A copy of the Scope of Hematology/Oncology Pharmacy Practice can be found here.

HOPA

HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has nearly 2000 members and includes oncology pharmacists, as well as pharmacy interns, residents, nurses, technicians, researchers, and administrators specializing in hematology/oncology practice. To learn more about HOPA, visit www.hoparx.org

This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com.

Media Contact:
Elizabeth Sherman 847.375.6307
esherman@hoparx.org


'/>"/>
SOURCE Hematology/Oncology Pharmacy Association (HOPA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RF Technologies Introduces New CodeWatch Designs for Wandering Management Solution
2. Elsevier Introduces SimChart for the Medical Office, a Hands-on EHR to Teach Medical Assistant Students Electronic Documentation
3. NxStage Introduces Web-Based Dosing Calculator
4. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
5. Flower Orthopedics Introduces New Standards for Delivering Cost-effective Orthopedic Surgery
6. Sciton Introduces Forever Bare BBL For Unprecedented Comfort in Hair Removal
7. Allscripts Introduces Population Health Analytics
8. Apeks introduces fully automated, closed loop CO2 extraction system for Botanical and Essential oil production
9. Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic
10. Innovative BioDefense Introduces Zylast Antiseptic Lotion
11. Gulf Coast Spine Care Introduces New Neck Pain Treatment Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):